questionsmedicales.fr
Composés hétérocycliques
Composés hétérocycliques à cycles fusionnés
Composés hétérobicycliques
Benzazépines
Benzodiazépines
Benzodiazépines : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Dépendance aux médicaments
Benzodiazépines
Tests de dépistage
Benzodiazépines
Troubles liés à l'usage de substances
Benzodiazépines
Évaluation clinique
Benzodiazépines
Syndrome de sevrage
Benzodiazépines
Symptômes
5
Effets indésirables
Benzodiazépines
Réactions allergiques
Benzodiazépines
Syndrome de sevrage
Benzodiazépines
Troubles cognitifs
Benzodiazépines
Urgences médicales
Benzodiazépines
Prévention
5
Prévention de la dépendance
Benzodiazépines
Éducation des patients
Benzodiazépines
Suivi médical
Benzodiazépines
Thérapies alternatives
Benzodiazépines
Sensibilisation
Benzodiazépines
Traitements
5
Dépendance aux médicaments
Benzodiazépines
Antidépresseurs
Benzodiazépines
Durée du traitement
Benzodiazépines
Complications
5
Complications
Benzodiazépines
Santé mentale
Benzodiazépines
Interactions médicamenteuses
Benzodiazépines
Troubles de la mémoire
Benzodiazépines
Facteurs de risque
5
Facteurs de risque
Benzodiazépines
Environnement social
Benzodiazépines
Antécédents familiaux
Benzodiazépines
Troubles mentaux
Benzodiazépines
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Benzodiazépines : Questions médicales les plus fréquentes",
"headline": "Benzodiazépines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Benzodiazépines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-04",
"dateModified": "2025-04-29",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Benzodiazépines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Benzazépines",
"url": "https://questionsmedicales.fr/mesh/D001552",
"about": {
"@type": "MedicalCondition",
"name": "Benzazépines",
"code": {
"@type": "MedicalCode",
"code": "D001552",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Alprazolam",
"alternateName": "Alprazolam",
"url": "https://questionsmedicales.fr/mesh/D000525",
"about": {
"@type": "MedicalCondition",
"name": "Alprazolam",
"code": {
"@type": "MedicalCode",
"code": "D000525",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.030"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Benzodiazépinones",
"alternateName": "Benzodiazepinones",
"url": "https://questionsmedicales.fr/mesh/D001570",
"about": {
"@type": "MedicalCondition",
"name": "Benzodiazépinones",
"code": {
"@type": "MedicalCode",
"code": "D001570",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Bromazépam",
"alternateName": "Bromazepam",
"url": "https://questionsmedicales.fr/mesh/D001960",
"about": {
"@type": "MedicalCondition",
"name": "Bromazépam",
"code": {
"@type": "MedicalCode",
"code": "D001960",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.110"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Clonazépam",
"alternateName": "Clonazepam",
"url": "https://questionsmedicales.fr/mesh/D002998",
"about": {
"@type": "MedicalCondition",
"name": "Clonazépam",
"code": {
"@type": "MedicalCode",
"code": "D002998",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dévazépide",
"alternateName": "Devazepide",
"url": "https://questionsmedicales.fr/mesh/D020109",
"about": {
"@type": "MedicalCondition",
"name": "Dévazépide",
"code": {
"@type": "MedicalCode",
"code": "D020109",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Diazépam",
"alternateName": "Diazepam",
"url": "https://questionsmedicales.fr/mesh/D003975",
"about": {
"@type": "MedicalCondition",
"name": "Diazépam",
"code": {
"@type": "MedicalCode",
"code": "D003975",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.216"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Nordazépam",
"alternateName": "Nordazepam",
"url": "https://questionsmedicales.fr/mesh/D003708",
"about": {
"@type": "MedicalCondition",
"name": "Nordazépam",
"code": {
"@type": "MedicalCode",
"code": "D003708",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.216.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Nordazépam",
"alternateName": "Nordazepam",
"url": "https://questionsmedicales.fr/mesh/D003708",
"about": {
"@type": "MedicalCondition",
"name": "Nordazépam",
"code": {
"@type": "MedicalCode",
"code": "D003708",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.216.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Flumazénil",
"alternateName": "Flumazenil",
"url": "https://questionsmedicales.fr/mesh/D005442",
"about": {
"@type": "MedicalCondition",
"name": "Flumazénil",
"code": {
"@type": "MedicalCode",
"code": "D005442",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.305"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Flunitrazépam",
"alternateName": "Flunitrazepam",
"url": "https://questionsmedicales.fr/mesh/D005445",
"about": {
"@type": "MedicalCondition",
"name": "Flunitrazépam",
"code": {
"@type": "MedicalCode",
"code": "D005445",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.320"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Flurazépam",
"alternateName": "Flurazepam",
"url": "https://questionsmedicales.fr/mesh/D005479",
"about": {
"@type": "MedicalCondition",
"name": "Flurazépam",
"code": {
"@type": "MedicalCode",
"code": "D005479",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.348"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lorazépam",
"alternateName": "Lorazepam",
"url": "https://questionsmedicales.fr/mesh/D008140",
"about": {
"@type": "MedicalCondition",
"name": "Lorazépam",
"code": {
"@type": "MedicalCode",
"code": "D008140",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.450"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nitrazépam",
"alternateName": "Nitrazepam",
"url": "https://questionsmedicales.fr/mesh/D009567",
"about": {
"@type": "MedicalCondition",
"name": "Nitrazépam",
"code": {
"@type": "MedicalCode",
"code": "D009567",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.565"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Oxazépam",
"alternateName": "Oxazepam",
"url": "https://questionsmedicales.fr/mesh/D010076",
"about": {
"@type": "MedicalCondition",
"name": "Oxazépam",
"code": {
"@type": "MedicalCode",
"code": "D010076",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.663"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pirenzépine",
"alternateName": "Pirenzepine",
"url": "https://questionsmedicales.fr/mesh/D010890",
"about": {
"@type": "MedicalCondition",
"name": "Pirenzépine",
"code": {
"@type": "MedicalCode",
"code": "D010890",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Prazépam",
"alternateName": "Prazepam",
"url": "https://questionsmedicales.fr/mesh/D011222",
"about": {
"@type": "MedicalCondition",
"name": "Prazépam",
"code": {
"@type": "MedicalCode",
"code": "D011222",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.784"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Témazépam",
"alternateName": "Temazepam",
"url": "https://questionsmedicales.fr/mesh/D013693",
"about": {
"@type": "MedicalCondition",
"name": "Témazépam",
"code": {
"@type": "MedicalCode",
"code": "D013693",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.070.880"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Chlordiazépoxyde",
"alternateName": "Chlordiazepoxide",
"url": "https://questionsmedicales.fr/mesh/D002707",
"about": {
"@type": "MedicalCondition",
"name": "Chlordiazépoxyde",
"code": {
"@type": "MedicalCode",
"code": "D002707",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Clobazam",
"alternateName": "Clobazam",
"url": "https://questionsmedicales.fr/mesh/D000078306",
"about": {
"@type": "MedicalCondition",
"name": "Clobazam",
"code": {
"@type": "MedicalCode",
"code": "D000078306",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.165"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Clorazépate dipotassique",
"alternateName": "Clorazepate Dipotassium",
"url": "https://questionsmedicales.fr/mesh/D003009",
"about": {
"@type": "MedicalCondition",
"name": "Clorazépate dipotassique",
"code": {
"@type": "MedicalCode",
"code": "D003009",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.180"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Estazolam",
"alternateName": "Estazolam",
"url": "https://questionsmedicales.fr/mesh/D004949",
"about": {
"@type": "MedicalCondition",
"name": "Estazolam",
"code": {
"@type": "MedicalCode",
"code": "D004949",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Médazépam",
"alternateName": "Medazepam",
"url": "https://questionsmedicales.fr/mesh/D008472",
"about": {
"@type": "MedicalCondition",
"name": "Médazépam",
"code": {
"@type": "MedicalCode",
"code": "D008472",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Midazolam",
"alternateName": "Midazolam",
"url": "https://questionsmedicales.fr/mesh/D008874",
"about": {
"@type": "MedicalCondition",
"name": "Midazolam",
"code": {
"@type": "MedicalCode",
"code": "D008874",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.575"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Olanzapine",
"alternateName": "Olanzapine",
"url": "https://questionsmedicales.fr/mesh/D000077152",
"about": {
"@type": "MedicalCondition",
"name": "Olanzapine",
"code": {
"@type": "MedicalCode",
"code": "D000077152",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.738"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Triazolam",
"alternateName": "Triazolam",
"url": "https://questionsmedicales.fr/mesh/D014229",
"about": {
"@type": "MedicalCondition",
"name": "Triazolam",
"code": {
"@type": "MedicalCode",
"code": "D014229",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.079.080.900"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Benzodiazépines",
"alternateName": "Benzodiazepines",
"code": {
"@type": "MedicalCode",
"code": "D001569",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Babette Bais",
"url": "https://questionsmedicales.fr/author/Babette%20Bais",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychiatry, Erasmus University Medical Centre Rotterdam, Rotterdam, Netherlands."
}
},
{
"@type": "Person",
"name": "Steven Wright",
"url": "https://questionsmedicales.fr/author/Steven%20Wright",
"affiliation": {
"@type": "Organization",
"name": "Former medical director of the Alliance for Benzodiazepine Best Practices, Portland, OR, a nonprofit resource for physicians and patients."
}
},
{
"@type": "Person",
"name": "Christine Champion",
"url": "https://questionsmedicales.fr/author/Christine%20Champion",
"affiliation": {
"@type": "Organization",
"name": "Université Lyon 1, Lyon, France, Hôpital des Charpennes, Hospices Civils de Lyon, Lyon, France."
}
},
{
"@type": "Person",
"name": "Teddy Novais",
"url": "https://questionsmedicales.fr/author/Teddy%20Novais",
"affiliation": {
"@type": "Organization",
"name": "Université Lyon 1, Lyon, France, Service pharmaceutique, Hôpital des Charpennes, Hospices Civils de Lyon, Lyon, France, Université Claude-Bernard Lyon 1, Research on Healthcare Performance (RESHAPE), Inserm U1290, Lyon, France."
}
},
{
"@type": "Person",
"name": "Jean-Michel Dorey",
"url": "https://questionsmedicales.fr/author/Jean-Michel%20Dorey",
"affiliation": {
"@type": "Organization",
"name": "Université Lyon 1, Lyon, France, Centre Hospitalier Le Vinatier, Bron, France."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Comparison of the Influence of Intraoperative Use of Sevoflurane and Isoflurane on Postoperative Nausea, Vomiting, and Cough.",
"datePublished": "2024-05-20",
"url": "https://questionsmedicales.fr/article/39034563",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4103/aam.aam_26_24"
}
},
{
"@type": "ScholarlyArticle",
"name": "The effect of desflurane, isoflurane and sevoflurane on the hemoglobin oxygen dissociation curve in human blood samples.",
"datePublished": "2022-08-10",
"url": "https://questionsmedicales.fr/article/35948604",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-17789-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Protective Effects of Dexmedetomidine Infusion on Genotoxic Potential of Isoflurane in Patients Undergoing Emergency Surgery.",
"datePublished": "2023-02-22",
"url": "https://questionsmedicales.fr/article/36874382",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2023/7414655"
}
},
{
"@type": "ScholarlyArticle",
"name": "Outcomes of children with life-threatening status asthmaticus requiring isoflurane therapy and extracorporeal life support.",
"datePublished": "2023-03-30",
"url": "https://questionsmedicales.fr/article/36927245",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/02770903.2023.2191715"
}
},
{
"@type": "ScholarlyArticle",
"name": "Volatile Sedation With Isoflurane in Neurocritical Care Patients After Poor-grade Aneurysmal Subarachnoid Hemorrhage.",
"datePublished": "2023-02-11",
"url": "https://questionsmedicales.fr/article/36780983",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.wneu.2023.02.032"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques à cycles fusionnés",
"item": "https://questionsmedicales.fr/mesh/D000072471"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés hétérobicycliques",
"item": "https://questionsmedicales.fr/mesh/D006574"
},
{
"@type": "ListItem",
"position": 5,
"name": "Benzazépines",
"item": "https://questionsmedicales.fr/mesh/D001552"
},
{
"@type": "ListItem",
"position": 6,
"name": "Benzodiazépines",
"item": "https://questionsmedicales.fr/mesh/D001569"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Benzodiazépines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Benzodiazépines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Benzodiazépines",
"description": "Comment diagnostiquer une dépendance aux benzodiazépines ?\nQuels tests sont utilisés pour évaluer l'usage des benzodiazépines ?\nQuels critères DSM sont utilisés pour le diagnostic ?\nComment évaluer l'efficacité d'un traitement par benzodiazépines ?\nQuels signes indiquent une surdose de benzodiazépines ?",
"url": "https://questionsmedicales.fr/mesh/D001569?mesh_terms=Isoflurane#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Benzodiazépines",
"description": "Quels sont les effets secondaires courants des benzodiazépines ?\nComment reconnaître une réaction allergique aux benzodiazépines ?\nQuels symptômes indiquent un sevrage des benzodiazépines ?\nLes benzodiazépines provoquent-elles des troubles cognitifs ?\nQuels symptômes peuvent nécessiter une consultation médicale urgente ?",
"url": "https://questionsmedicales.fr/mesh/D001569?mesh_terms=Isoflurane#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Benzodiazépines",
"description": "Comment prévenir la dépendance aux benzodiazépines ?\nQuels conseils donner aux patients sur l'utilisation des benzodiazépines ?\nComment surveiller l'utilisation des benzodiazépines ?\nQuelles stratégies non médicamenteuses peuvent aider ?\nComment sensibiliser sur les risques des benzodiazépines ?",
"url": "https://questionsmedicales.fr/mesh/D001569?mesh_terms=Isoflurane#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Benzodiazépines",
"description": "Comment traiter une dépendance aux benzodiazépines ?\nQuelles alternatives existent aux benzodiazépines pour l'anxiété ?\nComment réduire progressivement l'utilisation des benzodiazépines ?\nQuels médicaments peuvent aider à gérer le sevrage ?\nQuelle est la durée recommandée pour l'utilisation des benzodiazépines ?",
"url": "https://questionsmedicales.fr/mesh/D001569?mesh_terms=Isoflurane#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Benzodiazépines",
"description": "Quelles complications peuvent survenir avec l'usage prolongé ?\nComment les benzodiazépines affectent-elles la santé mentale ?\nQuels risques sont associés à l'association avec d'autres médicaments ?\nLes benzodiazépines peuvent-elles provoquer des chutes chez les personnes âgées ?\nQuels effets à long terme sur la mémoire sont observés ?",
"url": "https://questionsmedicales.fr/mesh/D001569?mesh_terms=Isoflurane#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Benzodiazépines",
"description": "Quels facteurs augmentent le risque de dépendance ?\nComment l'âge influence-t-il l'usage des benzodiazépines ?\nQuel rôle joue l'environnement social dans l'usage ?\nLes antécédents familiaux influencent-ils l'usage ?\nComment les troubles de santé mentale affectent-ils l'usage ?",
"url": "https://questionsmedicales.fr/mesh/D001569?mesh_terms=Isoflurane#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dépendance aux benzodiazépines ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'évaluation des symptômes et l'historique d'utilisation des médicaments."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'usage des benzodiazépines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de dépistage de drogues et des évaluations psychologiques peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels critères DSM sont utilisés pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères DSM-5 incluent l'usage excessif et les symptômes de sevrage."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité d'un traitement par benzodiazépines ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par la réduction des symptômes d'anxiété ou d'insomnie."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une surdose de benzodiazépines ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent confusion, somnolence excessive et difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires courants des benzodiazépines ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent somnolence, vertiges et troubles de la mémoire."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une réaction allergique aux benzodiazépines ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les réactions allergiques peuvent se manifester par éruptions cutanées et démangeaisons."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un sevrage des benzodiazépines ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes de sevrage incluent anxiété, insomnie et tremblements."
}
},
{
"@type": "Question",
"name": "Les benzodiazépines provoquent-elles des troubles cognitifs ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent entraîner des troubles de la mémoire et de la concentration."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent nécessiter une consultation médicale urgente ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme confusion sévère ou difficultés respiratoires nécessitent une urgence."
}
},
{
"@type": "Question",
"name": "Comment prévenir la dépendance aux benzodiazépines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut une prescription prudente et une éducation sur les risques."
}
},
{
"@type": "Question",
"name": "Quels conseils donner aux patients sur l'utilisation des benzodiazépines ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients doivent être informés des risques et de l'importance de suivre les prescriptions."
}
},
{
"@type": "Question",
"name": "Comment surveiller l'utilisation des benzodiazépines ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les médecins doivent effectuer des suivis réguliers pour évaluer l'usage et les effets."
}
},
{
"@type": "Question",
"name": "Quelles stratégies non médicamenteuses peuvent aider ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques comme la méditation et l'exercice physique peuvent réduire l'anxiété."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser sur les risques des benzodiazépines ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des campagnes d'information et des ateliers peuvent sensibiliser le public aux risques."
}
},
{
"@type": "Question",
"name": "Comment traiter une dépendance aux benzodiazépines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement inclut une désintoxication supervisée et une thérapie comportementale."
}
},
{
"@type": "Question",
"name": "Quelles alternatives existent aux benzodiazépines pour l'anxiété ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les alternatives incluent les antidépresseurs et les thérapies cognitivo-comportementales."
}
},
{
"@type": "Question",
"name": "Comment réduire progressivement l'utilisation des benzodiazépines ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La réduction doit être progressive, sous supervision médicale pour éviter le sevrage."
}
},
{
"@type": "Question",
"name": "Quels médicaments peuvent aider à gérer le sevrage ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme le diazépam peuvent être utilisés pour atténuer les symptômes de sevrage."
}
},
{
"@type": "Question",
"name": "Quelle est la durée recommandée pour l'utilisation des benzodiazépines ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation est généralement recommandée pour une courte durée, souvent moins de 4 semaines."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'usage prolongé ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'usage prolongé peut entraîner des troubles cognitifs et une dépendance sévère."
}
},
{
"@type": "Question",
"name": "Comment les benzodiazépines affectent-elles la santé mentale ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent aggraver des troubles mentaux comme la dépression et l'anxiété."
}
},
{
"@type": "Question",
"name": "Quels risques sont associés à l'association avec d'autres médicaments ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'association avec des opioïdes ou l'alcool augmente le risque de dépression respiratoire."
}
},
{
"@type": "Question",
"name": "Les benzodiazépines peuvent-elles provoquer des chutes chez les personnes âgées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles augmentent le risque de chutes et de fractures chez les personnes âgées."
}
},
{
"@type": "Question",
"name": "Quels effets à long terme sur la mémoire sont observés ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'usage prolongé peut entraîner des troubles de la mémoire et des difficultés d'apprentissage."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de dépendance ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents de troubles mentaux et l'usage prolongé augmentent le risque de dépendance."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il l'usage des benzodiazépines ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées sont plus susceptibles de subir des effets secondaires et des complications."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'environnement social dans l'usage ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un environnement stressant ou un manque de soutien social peut augmenter l'usage des benzodiazépines."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils l'usage ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de dépendance peuvent augmenter le risque d'usage problématique."
}
},
{
"@type": "Question",
"name": "Comment les troubles de santé mentale affectent-ils l'usage ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes avec des troubles de santé mentale sont plus susceptibles d'utiliser des benzodiazépines."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 29/04/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Department of Psychiatry, Erasmus University Medical Centre Rotterdam, Rotterdam, Netherlands.
Publications dans "Benzodiazépines" :
2 publications dans cette catégorie
Affiliations :
Former medical director of the Alliance for Benzodiazepine Best Practices, Portland, OR, a nonprofit resource for physicians and patients.
Publications dans "Benzodiazépines" :
2 publications dans cette catégorie
Affiliations :
Université Lyon 1, Lyon, France, Hôpital des Charpennes, Hospices Civils de Lyon, Lyon, France.
Publications dans "Benzodiazépines" :
2 publications dans cette catégorie
Affiliations :
Université Lyon 1, Lyon, France, Service pharmaceutique, Hôpital des Charpennes, Hospices Civils de Lyon, Lyon, France, Université Claude-Bernard Lyon 1, Research on Healthcare Performance (RESHAPE), Inserm U1290, Lyon, France.
Publications dans "Benzodiazépines" :
2 publications dans cette catégorie
Affiliations :
Université Lyon 1, Lyon, France, Centre Hospitalier Le Vinatier, Bron, France.
Publications dans "Benzodiazépines" :
2 publications dans cette catégorie
Affiliations :
Université Lyon 1, Lyon, France, Inserm U1028, CNRS UMR5292, Centre de recherche en neurosciences de Lyon, Lyon, France, Hôpital des Charpennes, Hospices Civils de Lyon, Lyon, France, Centre Mémoire Ressource et Recherche de Lyon (CMRR), Hôpital des Charpennes, Hospices Civils de Lyon, Lyon, France.
Publications dans "Benzodiazépines" :
2 publications dans cette catégorie
Affiliations :
Hôpital des Charpennes, Hospices Civils de Lyon, Lyon, France, CNRS UMR 5229, Institut des Sciences Cognitives Marc-Jeannerod, Team "Neuroplasticity in Parkinson's disease".
Publications dans "Benzodiazépines" :
2 publications dans cette catégorie
Affiliations :
Department of Psychiatry and Behavioral Neurosciences and Anesthesiology, Wayne State University, Detroit, MI, USA. rbalon@wayne.edu.
Publications dans "Benzodiazépines" :
2 publications dans cette catégorie
Affiliations :
Discipline of Psychiatry, Nepean Clinical School, Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Publications dans "Benzodiazépines" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
Publications dans "Benzodiazépines" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
Publications dans "Benzodiazépines" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
Publications dans "Benzodiazépines" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
Publications dans "Benzodiazépines" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry and Biochemistry, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
Milwaukee Institute of Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin, USA.
Publications dans "Benzodiazépines" :
2 publications dans cette catégorie
Affiliations :
Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Publications dans "Benzodiazépines" :
2 publications dans cette catégorie
Affiliations :
Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Publications dans "Benzodiazépines" :
2 publications dans cette catégorie
Affiliations :
UW Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Publications dans "Benzodiazépines" :
2 publications dans cette catégorie
Affiliations :
UW Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Publications dans "Benzodiazépines" :
2 publications dans cette catégorie
Affiliations :
UW Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Publications dans "Benzodiazépines" :
2 publications dans cette catégorie
Affiliations :
Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Publications dans "Benzodiazépines" :
Postoperative nausea, vomiting, and cough are the most common adverse effects of general anesthesia resulting in high discomfort to the patient resulting in uneasiness during the recovery period. This...
After approval from the institutional ethical committee, this quantitative observational institutional study was conducted on all patients aged between 18 and 65 years undergoing surgery under general...
All demographic parameters such as age, sex, American Society of Anesthesiologists physical status, and duration were comparable (P > 0.05). The sevoflurane group had higher number of patients (11 [14...
Sevoflurane was found to be better than isoflurane in terms of postoperative nausea vomiting and cough immediately after emergence in our study. Isoflurane cause the emergence of cough whereas no sign...
Desflurane, isoflurane and sevoflurane, three halogenated ethers, are commonly used inhaled anesthetics, both in the operating room and in the intensive care unit (ICU). The potency and dosage of thes...
Isoflurane (ISO) has been extensively uses in general anesthesia and reported to cause deoxyribonucleic acid (DNA) damage in prolonged surgical procedures. Dexmedetomidine (DEX) is an adrenergic agoni...
Increased level of antioxidants and decreased value of MDA and genetic damage index were seen in group B (...
Severe, refractory asthma is a life-threatening emergency that may be treated with isoflurane and extracorporeal life support. The objective of this study was to describe the clinical response to isof...
This was a retrospective descriptive study using electronic medical record data from two pediatric intensive care units within a single healthcare system in Atlanta, GA....
Forty-five children received isoflurane, and 14 children received extracorporeal life support, 9 without a trial of isoflurane. Hypercarbia and acidosis improved within four hours of starting isoflura...
Children who received isoflurane and/or ECLS had a high frequency of previous PICU admission and intubation. Improvement in ventilation and acidosis occurred within the first four hours of starting is...
Volatile sedation after aneurysmal subarachnoid hemorrhage (aSAH) promises several advantages, but there are still concerns regarding intracranial hypertension due to vasodilatory effects. We prospect...
Eleven patients were included in this prospective observational study. Between day 3 and 5 after admission, intravenous sedation was switched to isoflurane using the Sedaconda Anesthetic Conserving De...
There were no significant changes in mean ICP, CPP, and PBrO...
Isoflurane sedation does not compromise ICP or cerebral oxygenation in poor-grade aSAH patients, but the significant depression of CPP could limit the use of volatiles in case of hemodynamic instabili...
The quality of postanesthesia recovery is among the important issues of general anesthesia that affect the patient's ability to perform daily activities. This study hence aimed to investigate the effe...
This clinical trial was conducted on 80 women aged 30-65 years who visited Ayatollah Rouhani Hospital of Babol for an elective abdominal hysterectomy in 2020. Based on a randomized block design (4 blo...
The results showed that there was no significant difference between the two groups in terms of postoperative physical and mental changes (P = 0.142), except for the second night after surgery (P = 0.0...
Propofol outperformed isoflurane in terms of response time, quality of extubation, prevalence of PONV, and increase in blood pressure. In addition, the physical and mental QoR on the second night afte...
This study attempted to explore whether miR-363-3p play a role in the isoflurane (ISO)-mediated protective effect of cardiomyocyte injury induced by hypoxia/reoxygenation (H/R). A myocardial cell inju...
The objective of this systematic review was to estimate the relative risk of prolonged times to tracheal extubation with desflurane versus sevoflurane or isoflurane. Prolonged times are defined as ≥15...
To compare ICU-free (ICU-FD) and ventilator-free days (VFD) in the 30 days after randomization in patients that received isoflurane or propofol without receiving the other sedative....
A recent randomized controlled trial (RCT) compared inhaled isoflurane via the Sedaconda® anaesthetic conserving device (ACD) with intravenous propofol for up to 54 h (Meiser et al. 2021). After end o...
Sixty-nine of 150 patients randomized to isoflurane and 109 of 151 patients randomized to propofol were eligible. After adjusting for potential confounders, the isoflurane group had more ICU-FD than t...
Isoflurane via the ACD was not associated with more VFD but with more ICU-FD and less concomitant sedative use....
Isoflurane (ISO) is a type of anesthetic that might cause neurotoxicity in children. Although miR-424-5p is considerably downregulated in ISO-treated rat brain samples, its physiological role in ISO-i...